Morphogenesis, Inc. signs agreement with Novartis Animal Health to further the development of cancer immunotherapy for companion animals. read more

Morphogenesis is a privately held company with an intellectual property portfolio centered around cellular technologies. read more

We are driven by our commitment to the patients who will be treated with the clinical therapies we develop and the researchers... read more